Search
Search Results
##search.searchResults.foundPlural##
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2239PDF: 1220HTML: 3884 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1610PDF: 1059HTML: 263 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3760PDF: 1320HTML: 748Figure 2: 465Figure 1: 3143 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1098PDF: 755HTML: 113 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2160PDF: 1560HTML: 536 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2370PDF: 1022HTML: 7630Untitled: 290Fig2: 193Fig3: 186Fig4: 195 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2324PDF: 1046HTML: 5081Cover Letter: 175Figure 2: 173Figure 1: 182Figure 3: 208Figure 4: 179Figure Legend: 193Table 1: 200Table 2: 192Table 3: 191 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1291PDF: 1036HTML: 235 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3625PDF: 1543HTML: 4442CoverLetter: 191Figure1: 204 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3809PDF: 1616HTML: 573Figures . Eliassian: 233 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4493PDF: 1744HTML: 1095 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2914PDF: 1130HTML: 381Preferred Reviewers: 216 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4431PDF: 935HTML: 1333Table1: 190 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1407PDF: 1038HTML: 374Suppl. Figure: 190Suppl. Tables: 213 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3365PDF: 593HTML: 675 -
-
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2373PDF: 979HTML: 11142 -
COMPARATIVE ANALYSIS OF CLINICAL AND LABORATORY DATA IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 IN THE REPUBLIC OF KAZAKHSTAN MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
1063PDF: 580HTML: 342 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3493PDF: 1220HTML: 1147 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4599PDF: 1956HTML: 17861 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1243PDF: 726HTML: 1249 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8131PDF: 4311HTML: 7519 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5220PDF: 1352HTML: 2763Cover letter: 211 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2617PDF: 1029HTML: 180Suppl. Files: 525 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1796PDF: 891HTML: 388Fig1: 245Fig.2: 261Fig. 3: 197Fig. 5: 210Fig. 4: 233 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1491PDF: 981HTML: 428 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2808PDF: 996HTML: 624 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3301PDF: 1599HTML: 270 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4008PDF: 1324HTML: 2280 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6967PDF: 3688HTML: 808 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2573PDF: 960HTML: 324 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1435PDF: 838HTML: 3125 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2922PDF: 974HTML: 7354 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
2192PDF: 1031Html: 377







